Offer - Urjas Oil for just ₹ 1 X
Glubrim is a prescription drug, available for use as Drops. Secondary and off-label uses of Glubrim have also been mentioned below.
The right dosage of Glubrim depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Glubrim also has some side effects, the most common being Eye Burning, Eye irritation, Stinging in the Eyes. While these are the most often observed Glubrim side effects, there are can be others also. These have been listed below. These side effects of Glubrim are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Glubrim has a Mild effect for pregnant women and Unknown effect on lactating mothers. Warnings related to Glubrim's effects on the liver, heart and kidney, if any, have been listed below.
Glubrim is not recommended if you suffer from certain medical conditions as it can have adverse effects. Heart Failure, Diabetes, COPD (Chronic Obstructive Pulmonary Disease) are examples of such conditions. Other conditions have been mentioned below in the Glubrim contraindications section.
Besides this, Glubrim may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Glubrim, it is important to know that it is safe while driving, and is habit-forming.
Glubrim is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Glubrim safe for pregnant women?
Glubrim has little to no side effects in pregnant women.
Is the use of Glubrim safe during breastfeeding?
In the absence of any scientific study about the side effects of Glubrim in breastfeeding women, information on safety of Glubrim is unavailable.
What is the effect of Glubrim on the Kidneys?
Kidney can be affected by Glubrim. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Glubrim on the Liver?
You may experience side effects on your liver after taking Glubrim. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Glubrim on the Heart?
There may be an adverse effect on the heart after taking Glubrim. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Glubrim should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Glubrim unless your doctor advises you to do so -
Is this Glubrim habit forming or addictive?
No, there is no any evidence that Glubrim is addictive.
Interaction between Food and Glubrim
Taking Glubrim with food does not harm your health.
Interaction between Alcohol and Glubrim
Information about the interaction of Glubrim and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Istalol® (timolol maleate ophthalmic solution)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1401
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 153
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1405
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 154
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Alphagan® (brimonidine tartrate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Simbrinza™ (brinzolamide/brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Enidin® (brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Alphagan® P (brimonidine tartrate)